骨内デバイスの世界市場：市場規模（種類別・エンドユーザー別・地域別）、将来予測

骨内デバイスの市場規模と予測

骨内デバイスの市場規模は、2024年に4億1,282万米ドルと評価され、2026年から2032年にかけて4.63%のCAGRで成長し、2032年には5億9,294万米ドルに達すると予測されています。

心停止などの様々な疾患の高い有病率、外傷を含む緊急事態、軍事的関与の増加は、世界の骨内デバイス市場の成長を促進すると予想されます。政府および規制当局の承認数の増加が、骨内デバイス市場の基盤であることを証明しています。また、研究開発活動の活発化や公衆衛生に対する意識の高まりが市場成長を促進しています。当レポートでは、世界の骨内デバイス市場について包括的な評価を行います。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界の骨内デバイス市場の定義

骨内デバイスは、生命を脅かす状態に対処するために使用される緊急医療機器です。骨内デバイスは、静脈アクセスがない緊急時に薬物や生命維持に必要な水分を供給するために使用されます。骨内血管は、緊急時に即座に医療介入を行うための代替方法です。装置は骨の髄腔に素早く挿入され、装置の正確な位置が、装置内への点滴液の流れによって示されます。

挿入部周辺に体液の滲出が生じた場合は、コンパートメント症候群の拡大を防ぐために装置を除去します。しかし、骨髄の吸引は、装置の正しい位置を確認するもう一つの方法です。骨内デバイスは迅速、簡便、効果的です。この装置は、骨髄を介して全身循環に直接薬剤を注入するもので、緊急時や遅延時に有用です。これらの装置は血液学/腫瘍学患者、外傷、心停止、糖尿病患者の治療に使用されます。

世界の骨内デバイス市場の概要

静脈バスキュラーアクセスの失敗とともに傷害が増加していることから、当面の間、骨内デバイス市場が活性化すると予想されます。骨内注入は、他の投与経路では望ましい効果が得られない心肺蘇生のための安全で効率的な技術です。

心停止のような複数の疾患の高い有病率、外傷のような緊急事態、および軍事的関与の高まりが、世界の骨内デバイス市場を牽引しています。一人当たり所得の増加や高度医療への投資意欲の高まりも需要を促進しています。腹腔内注入は、水分や薬剤の静脈内投与が不可能な小児の病院前緊急事態で最も頻繁に使用されます。複数の疾患タイプの有病率の上昇や外傷性手術の件数が、今後数年間、これらの装置の需要を促進すると思われます。

挿入中の骨折、管理中の薬剤の滲出、挿入部位の感染症などのリスクや、高額な薬剤費、看護師の医療専門知識不足、不十分な機器管理などが、骨内デバイス市場の潜在的な抑制要因となっています。規制当局による承認の増加、M&A、新興経済諸国が創出した新市場は、市場に有利な成長機会をもたらしています。

目次

第1章 世界の骨内デバイス市場：イントロダクション

• 市場概要
• 分析範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの分析手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界の骨内デバイス市場の展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 世界の骨内デバイス市場：種類別

• 概要
• 手動
• 半自動
• 自動

第6章 世界の骨内デバイス市場：エンドユーザー別

• 概要
• 病院
• 救急医療サービス（EMS）
• 軍事
• その他

第7章 世界の骨内デバイス市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋
• その他の地域 (ROW)
  • ラテンアメリカ
  • 中東・アフリカ

第8章 世界の骨内デバイス市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な開発戦略

第9章 企業プロファイル

• Teleflex Incorporated
• PERSYS MEDICAL
• Cook
• BD
• Biopsybell
• Pyng Medical Corp.
• Aero Healthcare
• Vidacare Corporation
• Carefusion Inc.

第10章 付録

• 関連分析

Intraosseous Devices Market Size And Forecast

Intraosseous Devices Market size was valued at USD 412.82 Million in 2024 and is projected to reach USD 592.94 Million by 2032, growing at a CAGR of 4.63% from 2026 to 2032.

The high prevalence of various diseases, such as cardiac arrest, emergencies including trauma, and increasing military engagements are expected to fuel the growth of the global Intraosseous Devices Market. Growth in the number of government and regulatory approvals is proving to be the foundation for the Intraosseous Devices Market. In addition, the increasing research and development activities as well as the increased awareness about public health is driving the market growth. The Global Intraosseous Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Intraosseous Devices Market Definition

Intraosseous devices are emergency medical equipment used for dealing with life-threatening conditions. Intraosseous devices can be used to supply medications and vital fluids in an emergency when venous access is absent. Intraosseous vascular is an alternative method for immediate medical intervention during emergency conditions. The device is quickly inserted into the medullary space of bone and accurate positioning of the device is indicated by the flow of intravenous fluid into the device.

If extravasation of the fluid around the insertion area occurs, the device is removed to prevent the growth of compartment syndrome. However, aspiration of bone marrow signifies another method to confirm the correct positioning of the device. Intraosseous devices are quick, easy, and effective. This device infuses medication directly into systemic circulation via bone marrow and is useful in emergency and delayed situations. These devices are used in the treatment of hematology/oncology patients, traumas, cardiac arrest, and diabetic patients.

Global Intraosseous Devices Market Overview

The increasing number of injuries, along with the failure of intravenous vascular access, is expected to fuel the market for intraosseous devices in the immediate future. Intraosseous infusion is a secure and efficient technology for cardiopulmonary resuscitation where other routes of administration struggle to achieve the desired impact.

The high prevalence of multiple diseases such as cardiac arrest, emergencies such as trauma, and rising military engagements are driving the global Intraosseous Devices Market. The increasing per capita income and a growing willingness to invest in advanced care are also fueling demand. Intraosseous infusion is most often used in pediatric pre-hospital emergencies where intravenous administration of fluids and medications is impossible. The rising prevalence of multiple disease types, as well as the number of traumatic surgeries, are likely to drive demand for these devices in the coming years.

The risks such as fractures during insertion, extravasation of drugs being managed, infections at the insertion site, as well as high medication costs, a shortage of medical expertise for nurses, and poor equipment management, are potential factors restraining the Intraosseous Devices Market. The rising regulatory approvals, mergers and acquisitions, and new markets created by developing economies present favorable growth opportunities in the market.

Global Intraosseous Devices Market Segmentation Analysis

The Global Intraosseous Devices Market is Segmented on the basis of Type, End-User, And Geography.

Intraosseous Devices Market, By Type

• Manual
• Semi-Automatic
• Automatic

Based on Type, The market is segmented into Manual, Semi-Automatic, and Automatic. The automatic and semi-automatic segments are projected to grow because they are more technologically advanced than the manual.

Intraosseous Devices Market, By End-User

• Hospitals
• Emergency Medical Services (EMS)
• Military
• Others

Based on End-User, The market is segmented into Hospitals, Emergency Medical Services (EMS), Military, and Others. Due to the increased number of emergency situations, expanding medical personnel and specialized personnel, and growing patient population cases, the EMS segment is projected to lead the global Intraosseous Devices Market.

Intraosseous Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, The Global Intraosseous Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America has the strongest market share and is expected to grow in the coming years. The demand in North America is primarily led by an increase in the number of emergency cases, cardiac cases, and multiple diseases requiring immediate vascular access, as well as an increase in the acceptance of advanced products, a large number of medical practitioners, and specialized personnel, and the involvement of prominent players in these regions.

Key Players

The "Global Intraosseous Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Teleflex Incorporated, PERSYS MEDICAL, Cook, BD, Biopsybell, Pyng Medical Corp., Aero Healthcare, Vidacare Corporation, Carefusion Inc., and Others. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• Mergers and Acquisitions
• In December 2013, Teleflex Incorporated acquired Vidacare Corporation, a provider of intraosseous, or into the bone, access devices. This acquisition complemented the vascular access and specialty product portfolio of the company's critical care product group.
• Product Launches and Product Expansions
• In March 2020, SAM Medical launched SAM IO Intraosseous Access System for pre-hospital and hospital healthcare providers in the civilian and military sectors.
• In November 2019, Piper Access, LLC received FDA 510(k) clearance for Piper Go-IO Intraosseous Infusion System from Piper Access.
• In May 2018, TraumaFX, a division of Kforce Government Solutions, Inc. and a global provider of ruggedized human and canine medical training simulators, launched K9 Diesel, a canine medical simulator.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL INTRAOSSEOUS DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL INTRAOSSEOUS DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.2 Porters Five Force Model
• 4.3 Value Chain Analysis

5 GLOBAL INTRAOSSEOUS DEVICES MARKET, BY TYPE

• 5.1 Overview
• 5.2 Manual
• 5.3 Semi-Automatic
• 5.4 Automatic

6 GLOBAL INTRAOSSEOUS DEVICES MARKET, BY END-USER

• 6.1 Overview
• 6.2 Hospitals
• 6.3 Emergency Medical Services (EMS)
• 6.4 Military
• 6.5 Others

7 GLOBAL INTRAOSSEOUS DEVICES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL INTRAOSSEOUS DEVICES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Teleflex Incorporated
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 PERSYS MEDICAL
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Cook
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 BD
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Biopsybell
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Pyng Medical Corp.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Aero Healthcare
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Vidacare Corporation
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Carefusion Inc.
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments

10 APPENDIX

• 10.1 Related Research